Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on giant cell arteritis.

Grant W Su1, Rod Foroozan

  • 1Cullen Eye Institute, Baylor College of Medicine, Houston, Texas 77030, USA.

Current Opinion in Ophthalmology
|November 15, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reply to: A Lethal Progressive Neuroinflammation Disguised as MOGAD Revealing a Final Diagnosis of Griscelli Syndrome: Regarding: MOGAD is the Most Common Cause of Isolated Optic Neuritis in Children.

Annals of clinical and translational neurology·2026
Same author

MOGAD Is the Most Common Cause of Isolated Optic Neuritis in Children.

Annals of clinical and translational neurology·2026
Same author

Variability in Lumbar Puncture Assessment in Patients With Papilledema From Idiopathic Intracranial Hypertension: A Multi-Institutional Review.

The neurologist·2026
Same author

Reply to "Catching up with the planet of the apex".

Survey of ophthalmology·2025
Same author

MOGAD optic neuritis after mild head/orbital trauma in six children.

Journal of neuroimmunology·2025
Same author

Opsoclonus in Alternating Hemiplegia of Childhood Secondary to ATP1A3 p.Gly803Arg.

Movement disorders clinical practice·2024
Same journal

Laser vision correction (LASIK, PRK, SMILE) with simultaneous accelerated corneal crosslinking.

Current opinion in ophthalmology·2026
Same journal

Traumatic macular hole: observe, operate, or other options.

Current opinion in ophthalmology·2026
Same journal

The evolving role of artificial intelligence in ophthalmology: basic science, translation, and clinical integration.

Current opinion in ophthalmology·2026
Same journal

Editorial: reducing risk for refractive surgery.

Current opinion in ophthalmology·2026
Same journal

Updates on Refractive Surgery: Benefits, Risks, and Costs of Modern Treatment Options.

Current opinion in ophthalmology·2026
Same journal

Corneal Allogeneic Intrastromal Ring Segments for keratoconus - recent evidence and the move to customized and custom shaped CAIRS.

Current opinion in ophthalmology·2026
See all related articles

Giant cell arteritis (GCA) is a common vasculitis causing vision loss in older adults. Current treatments, primarily corticosteroids, offer limited visual recovery, necessitating improved diagnostic and management strategies for GCA patients.

Area of Science:

  • Rheumatology
  • Ophthalmology
  • Internal Medicine

Background:

  • Giant cell arteritis (GCA) is the most prevalent systemic vasculitis.
  • It disproportionately affects the elderly population.
  • GCA is a leading cause of preventable visual loss in older adults.

Purpose of the Study:

  • To review current diagnostic approaches for GCA.
  • To discuss contemporary treatment strategies for GCA.
  • To evaluate the visual prognosis in patients diagnosed with GCA.

Main Methods:

  • Literature review of recent evidence on GCA diagnosis and management.
  • Analysis of treatment outcomes and visual prognosis.
  • Development of a clinical algorithm for GCA evaluation.

Related Experiment Videos

Main Results:

  • Visual function recovery in GCA patients with existing visual loss is generally poor.
  • Corticosteroids remain the cornerstone of GCA treatment.
  • An evaluation and management algorithm for suspected GCA has been developed.

Conclusions:

  • Despite advancements, corticosteroids are the standard therapy for GCA.
  • Early diagnosis and prompt treatment are crucial for managing GCA.
  • The visual prognosis for GCA patients with visual impairment remains guarded.